First Time Loading...

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 365.08 USD 0.02% Market Closed
Updated: May 6, 2024

West Pharmaceutical Services Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

West Pharmaceutical Services Inc
Net Income (Common) Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
West Pharmaceutical Services Inc
NYSE:WST
Net Income (Common)
$568.7m
CAGR 3-Years
10%
CAGR 5-Years
21%
CAGR 10-Years
18%
Thermo Fisher Scientific Inc
NYSE:TMO
Net Income (Common)
$6B
CAGR 3-Years
-2%
CAGR 5-Years
15%
CAGR 10-Years
17%
Danaher Corp
NYSE:DHR
Net Income (Common)
$8.1B
CAGR 3-Years
21%
CAGR 5-Years
27%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Net Income (Common)
$788.8m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
10%
Agilent Technologies Inc
NYSE:A
Net Income (Common)
$1.2B
CAGR 3-Years
15%
CAGR 5-Years
2%
CAGR 10-Years
5%
IQVIA Holdings Inc
NYSE:IQV
Net Income (Common)
$1.4B
CAGR 3-Years
69%
CAGR 5-Years
39%
CAGR 10-Years
20%

See Also

What is West Pharmaceutical Services Inc's Net Income (Common)?
Net Income (Common)
568.7m USD

Based on the financial report for Mar 31, 2024, West Pharmaceutical Services Inc's Net Income (Common) amounts to 568.7m USD.

What is West Pharmaceutical Services Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
18%

Over the last year, the Net Income (Common) growth was 3%. The average annual Net Income (Common) growth rates for West Pharmaceutical Services Inc have been 10% over the past three years , 21% over the past five years , and 18% over the past ten years .